Description
Glifempa-M 10/500mg Tablets (30’s)
Glifempa-M 10/500mg is a fixed-dose combination of Empagliflozin (10mg) and Metformin Hydrochloride (500mg), used for the effective management of type 2 diabetes mellitus. This dual-action therapy supports improved blood sugar control and metabolic health.
Key Features:
-
Empagliflozin (SGLT2 inhibitor): Promotes urinary glucose excretion, aiding in blood sugar reduction and weight control.
-
Metformin (Biguanide): Reduces hepatic glucose production and improves insulin sensitivity.
-
Dual mechanism for enhanced glycemic control.
-
Once or twice daily oral tablet depending on clinical recommendation.
-
May contribute to cardiovascular and renal benefits in diabetic patients.
Indications:
-
Adults with type 2 diabetes mellitus who are inadequately controlled on metformin alone or require combination therapy.
-
As an adjunct to diet and exercise for improved blood glucose management.
Dosage & Administration:
-
Typically taken once or twice daily with meals to reduce gastrointestinal side effects.
-
Dosage individualized based on glycemic response and tolerability.
-
Regular monitoring of blood glucose and renal function is recommended.
Precautions:
-
Not for use in type 1 diabetes or diabetic ketoacidosis.
-
Caution in patients with renal or hepatic impairment.
-
Monitor for signs of lactic acidosis, dehydration, and urinary tract infections.
-
Avoid alcohol and inform your doctor of all current medications.
Possible Side Effects:
-
Nausea, abdominal discomfort (mainly due to Metformin)
-
Increased urination, urinary/genital infections
-
Headache, dizziness
-
Rare: Lactic acidosis (serious but uncommon)
Storage:
-
Store in a cool, dry place below 25°C.
-
Keep out of reach of children.
Reviews
There are no reviews yet.